{
    "nctId": "NCT02020837",
    "briefTitle": "A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema",
    "officialTitle": "A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema",
    "overallStatus": "TERMINATED",
    "conditions": "Lymphedema, Post Mastectomy",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 2,
    "primaryOutcomeMeasure": "Changes Relative to Baseline in the Volume of the Affected Limb at 3 and 6 Months From Surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject is 18-70 years of age\n* Subject is Stage II-IV unilateral lymphedema\n\nExclusion Criteria:\n\n* Subject is less than 6 months from completion of cancer treatment\n* Subject has allergic reaction to the lymphatic contrast agent (Indocyanine Blue)\n* Subject is medically unfit for the procedure\n* Subject is unable to complete the follow-up visits\n* Women with a positive urine pregnancy test are excluded from this study; women of childbearing potential (defined as those who have not undergone a hysterectomy or who have not been postmenopausal for at least 24 consecutive months) must agree to refrain from breast feeding and practice adequate contraception as specified in the informed consent. Adequate contraception consists of oral contraceptive, implantable contraceptives, injectable contraceptives, a double barrier method, or abstinence.\n* Subject has bilateral lymphedema",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}